329 related articles for article (PubMed ID: 10938397)
1. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
2. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis.
Wang QS; Papanikolaou A; Nambiar PR; Rosenberg DW
Mol Carcinog; 2000 Jul; 28(3):139-47. PubMed ID: 10942530
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
[TBL] [Abstract][Full Text] [Related]
5. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
9. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
Park B; Jang JS; Park K
Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
[TBL] [Abstract][Full Text] [Related]
10. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors.
Shao J; Sheng H; Aramandla R; Pereira MA; Lubet RA; Hawk E; Grogan L; Kirsch IR; Washington MK; Beauchamp RD; DuBois RN
Carcinogenesis; 1999 Feb; 20(2):185-91. PubMed ID: 10069452
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
14. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.
Wang QS; Papanikolaou A; Sabourin CL; Rosenberg DW
Carcinogenesis; 1998 Nov; 19(11):2001-6. PubMed ID: 9855016
[TBL] [Abstract][Full Text] [Related]
17. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
18. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
Jakowlew SB; Moody TW; You L; Mariano JM
Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
[TBL] [Abstract][Full Text] [Related]
19. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones.
Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M
Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653
[TBL] [Abstract][Full Text] [Related]
20. Multistage gene expression profiling in a differentially susceptible mouse colon cancer model.
Guda K; Cui H; Garg S; Dong M; Nambiar PR; Achenie LE; Rosenberg DW
Cancer Lett; 2003 Feb; 191(1):17-25. PubMed ID: 12609705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
